Posts Tagged: "university of southern california"

USC Launches its First IP Course for Undergrads

USC’s new course is premised on the notion that IP questions lie at the heart of a great many areas of modern life today — From Silicon Valley startups to Fortune 500 board rooms, from MIT engineering labs to Wall Street trading desks, and from industry trade conferences to the trade policy debates raging in Congress. Indeed, it is difficult to pick up a newspaper, or read any online magazine, without reading news about how intellectual property is impacting daily life and business… The brainchild of USC President C. L. Max Nikias and billionaire medical inventor Dr. Gary Michelson, USC new undergrad course in intellectual property — named The Entrepreneur’s Guide to Intellectual Property — just launched this fall. Taught by Kirkland & Ellis partner Luke Dauchot, with a phalanx of IP luminaries as guest speakers —including Marshall Phelps, former USPTO director David Kappos, Facebook IP chief Allen Lo, Dolby General Counsel Andy Sherman, and Xiaomi chief of IP strategy Paul Lin, among others.

Putting the pieces together on how to cure Alzheimer’s

The most common form of dementia is Alzheimer’s disease, a progressive disorder of the human brain which over time reduces a person’s cognitive abilities to the point that they cannot carry out the most basic tasks. This terrible disease was thrust back into the national conscious as the result of the death of Nancy Reagan. With this in mind we thought we might take a moment to review what scientists know about Alzheimer’s disease and what treatments and cures are currently being pursued.

Bolder initiatives needed to take next steps in fight against cancer

February 4 is World Cancer Day… There has been steady progress made in the history of treating cancers of many types since the administration of former U.S President Richard Nixon, according to Dr. Boris Pasche, the Director of the Wake Forest Baptist Medical Center’s Comprehensive Cancer Center. “In my opinion, government should embark on bold new initiatives in cancer treatment,” Pasche said. He did note that, while what President Obama says as a statesman doesn’t change the humbling reality that many cancers have so far stumped medical scientists. Nevertheless, increased investments into cancer research have dramatically impacted survival rates. Over the past decade, most cancers show a better outcome than they did ten years ago. “Bolder initiatives with disruptive approaches to cancer are in order if we want to make leaps forward more quickly,” Pasche said.

Licensing Executives Society Announces 2010 Deals of Distinction™ Awards

In May 2009, Genzyme Corporation acquired the worldwide rights to a potential breakthrough treatment for Multiple Sclerosis (MS) along with three marketed oncology products from Bayer Healthcare Pharmaceuticals. In February, the University of Pennsylvania (Penn) and AstraZeneca forged a new collaborative research agreement, featuring a significant licensing component, that makes use of their respective talents and resources to generate new Alzheimer’s Disease (AD) drug candidates for the clinical development pipeline.